Cargando…

Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectiveness

BACKGROUND: A first pilot study showed that an image-guided navigation system could improve resection margin rates in locally advanced (LARC) and locally recurrent rectal cancer (LRRC) patients. Incremental surgical innovation is often implemented without reimbursement consequences, health economic...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindenberg, Melanie, Kramer, Astrid, Kok, Esther, Retèl, Valesca, Beets, Geerard, Ruers, Theo, van Harten, Wim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074374/
https://www.ncbi.nlm.nih.gov/pubmed/35524234
http://dx.doi.org/10.1186/s12885-022-09561-w
_version_ 1784701468780003328
author Lindenberg, Melanie
Kramer, Astrid
Kok, Esther
Retèl, Valesca
Beets, Geerard
Ruers, Theo
van Harten, Wim
author_facet Lindenberg, Melanie
Kramer, Astrid
Kok, Esther
Retèl, Valesca
Beets, Geerard
Ruers, Theo
van Harten, Wim
author_sort Lindenberg, Melanie
collection PubMed
description BACKGROUND: A first pilot study showed that an image-guided navigation system could improve resection margin rates in locally advanced (LARC) and locally recurrent rectal cancer (LRRC) patients. Incremental surgical innovation is often implemented without reimbursement consequences, health economic aspects should however also be taken into account. This study evaluates the early cost-effectiveness of navigated surgery compared to standard surgery in LARC and LRRC. METHODS: A Markov decision model was constructed to estimate the expected costs and outcomes for navigated and standard surgery. The input parameters were based on pilot data from a prospective (navigation cohort n = 33) and retrospective (control group n = 142) data. Utility values were measured in a comparable group (n = 63) through the EQ5D-5L. Additionally, sensitivity and value of information analyses were performed. RESULTS: Based on this early evaluation, navigated surgery showed incremental costs of €3141 and €2896 in LARC and LRRC. In LARC, navigated surgery resulted in 2.05 Quality-Adjusted Life Years (QALYs) vs 2.02 QALYs for standard surgery. For LRRC, we found 1.73 vs 1.67 QALYs respectively. This showed an Incremental Cost-Effectiveness Ratio (ICER) of €136.604 for LARC and €52.510 for LRRC per QALY gained. In scenario analyses, optimal utilization rates of the navigation technology lowered the ICER to €61.817 and €21.334 for LARC and LRRC. The ICERs of both indications were most sensitive to uncertainty surrounding the risk of progression in the first year after surgery, the risk of having a positive surgical margin, and the costs of the navigation system. CONCLUSION: Adding navigation system use is expected to be cost-effective in LRRC and has the potential to become cost-effective in LARC. To increase the probability of being cost-effective, it is crucial to optimize efficient use of both the hybrid OR and the navigation system and identify subgroups where navigation is expected to show higher effectiveness. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09561-w.
format Online
Article
Text
id pubmed-9074374
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90743742022-05-07 Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectiveness Lindenberg, Melanie Kramer, Astrid Kok, Esther Retèl, Valesca Beets, Geerard Ruers, Theo van Harten, Wim BMC Cancer Research Article BACKGROUND: A first pilot study showed that an image-guided navigation system could improve resection margin rates in locally advanced (LARC) and locally recurrent rectal cancer (LRRC) patients. Incremental surgical innovation is often implemented without reimbursement consequences, health economic aspects should however also be taken into account. This study evaluates the early cost-effectiveness of navigated surgery compared to standard surgery in LARC and LRRC. METHODS: A Markov decision model was constructed to estimate the expected costs and outcomes for navigated and standard surgery. The input parameters were based on pilot data from a prospective (navigation cohort n = 33) and retrospective (control group n = 142) data. Utility values were measured in a comparable group (n = 63) through the EQ5D-5L. Additionally, sensitivity and value of information analyses were performed. RESULTS: Based on this early evaluation, navigated surgery showed incremental costs of €3141 and €2896 in LARC and LRRC. In LARC, navigated surgery resulted in 2.05 Quality-Adjusted Life Years (QALYs) vs 2.02 QALYs for standard surgery. For LRRC, we found 1.73 vs 1.67 QALYs respectively. This showed an Incremental Cost-Effectiveness Ratio (ICER) of €136.604 for LARC and €52.510 for LRRC per QALY gained. In scenario analyses, optimal utilization rates of the navigation technology lowered the ICER to €61.817 and €21.334 for LARC and LRRC. The ICERs of both indications were most sensitive to uncertainty surrounding the risk of progression in the first year after surgery, the risk of having a positive surgical margin, and the costs of the navigation system. CONCLUSION: Adding navigation system use is expected to be cost-effective in LRRC and has the potential to become cost-effective in LARC. To increase the probability of being cost-effective, it is crucial to optimize efficient use of both the hybrid OR and the navigation system and identify subgroups where navigation is expected to show higher effectiveness. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09561-w. BioMed Central 2022-05-06 /pmc/articles/PMC9074374/ /pubmed/35524234 http://dx.doi.org/10.1186/s12885-022-09561-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Lindenberg, Melanie
Kramer, Astrid
Kok, Esther
Retèl, Valesca
Beets, Geerard
Ruers, Theo
van Harten, Wim
Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectiveness
title Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectiveness
title_full Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectiveness
title_fullStr Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectiveness
title_full_unstemmed Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectiveness
title_short Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectiveness
title_sort image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectiveness
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074374/
https://www.ncbi.nlm.nih.gov/pubmed/35524234
http://dx.doi.org/10.1186/s12885-022-09561-w
work_keys_str_mv AT lindenbergmelanie imageguidednavigationforlocallyadvancedprimaryandlocallyrecurrentrectalcancerevaluationofitsearlycosteffectiveness
AT kramerastrid imageguidednavigationforlocallyadvancedprimaryandlocallyrecurrentrectalcancerevaluationofitsearlycosteffectiveness
AT kokesther imageguidednavigationforlocallyadvancedprimaryandlocallyrecurrentrectalcancerevaluationofitsearlycosteffectiveness
AT retelvalesca imageguidednavigationforlocallyadvancedprimaryandlocallyrecurrentrectalcancerevaluationofitsearlycosteffectiveness
AT beetsgeerard imageguidednavigationforlocallyadvancedprimaryandlocallyrecurrentrectalcancerevaluationofitsearlycosteffectiveness
AT ruerstheo imageguidednavigationforlocallyadvancedprimaryandlocallyrecurrentrectalcancerevaluationofitsearlycosteffectiveness
AT vanhartenwim imageguidednavigationforlocallyadvancedprimaryandlocallyrecurrentrectalcancerevaluationofitsearlycosteffectiveness